03.12.2012 • News • AkzoNobel • chemical industry • Management

CEO Ton Büchner Returns to AkzoNobel

The Supervisory Board of AkzoNobel is delighted to announce that CEO Ton Büchner will resume his duties on Friday, December 7, following a full recovery.

"On behalf of the Supervisory Board and the Executive Committee we welcome Ton coming back to the office. It has obviously been a testing time for all of us but now Ton is back as expected, leading the company forward and returning to business as usual," said Karel Vuursteen, Chairman of the Supervisory Board.

AkzoNobel will organize an analyst conference call and media interviews on Friday, December 14. Supervisory Board member Antony Burgmans, and CEO Ton Büchner will answer questions relating to this announcement.

On February 20, 2013, AkzoNobel will announce its Q4 and Full Year 2012 results, and Ton Büchner will give the Strategy Update, postponed from October 22.

 

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Top-Feature